Evaluating Drug Risk Using GAN and SMOTE Based on CFDA's Spontaneous Reporting Data

Adverse drug reactions (ADRs) pose health threats to humans. Therefore, the risk re-evaluation of post-marketing drugs has become an important part of the pharmacovigilance work of various countries. In China, drugs are mainly divided into three categories, from high-risk to low-risk drugs, namely,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jianxiang, Feng, Guanzhong, Lu, Zhiqiang, Han, Pu, Zhu, Yunxia, Huang, Weidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418931/
https://www.ncbi.nlm.nih.gov/pubmed/34493954
http://dx.doi.org/10.1155/2021/6033860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418931/
https://www.ncbi.nlm.nih.gov/pubmed/34493954
http://dx.doi.org/10.1155/2021/6033860

Ejemplares similares